# Baclofen

## Baclospas 5mg

##### 

| TAH Drug Code      | OBAC5                                                                                                                                                                                                                                                                                                                                                     |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Alleviation of signs & symptoms of painful spasticity resulting from cerebral & spinal cord injuries, multiple sclerosis, cerebral palsy, trigeminal neuralgia, low back syndrome, flexor spasm, tardive dyskinesia.                                                                                                                                      |
| Dosing             | Adult: Initially 5-15 mg daily divided in 1-3 doses. May increase dosage by 15 mg/day increments every 3 days until optimum effect is achieved. Usual daily dose is 30 mg. (MicroMedex maximum: 80mg/day) Children: Initially 5 mg daily in 2 divided doses. Usual daily dose: 4-6 years old, 5-15 mg; 7-11 years old, 5-20 mg; 12-15 years old, 5-25 mg. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                             |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                  |
| Contraindications  | Epilepsy or convulsive disorders.                                                                                                                                                                                                                                                                                                                         |
| Adverse Effects    | Sedation, headache, GI disturbances. Gastrointestinal: Nausea, Vomiting Musculoskeletal: Poor muscle tone Neurologic: Asthenia (5% to 15% ), Dizziness (5% to 15% ), Headache (4% to 8% ), Somnolence (10 to 63% )                                                                                                                                        |
| Pregnancy          | Human (and Animal) Data Suggest Risk                                                                                                                                                                                                                                                                                                                      |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                             |

